VARIABLE | Good QoL (%) | Poor QoL (%) | COR (95% CI) | p value |
---|---|---|---|---|
Age category in years | ||||
ā18ā35 | 28 (41.2) | 19 (32.8) | 1.0 | Ā |
ā36ā59 | 30 (44.1) | 28 (48.3) | 1.38 (0.6ā4.6) | 0.42 |
ā60ā80 | 10 (14.7) | 11 (19.0) | 1.62 (0.6ā4.6) | 0.36 |
Gender | ||||
āfemale | 40 (58.8) | 33 (56.9) | 1.0 | Ā |
āmale | 28 (41.2) | 25 (43.1) | 1.08 (0.5ā2.2) | 0.83 |
Monthly income | ||||
āā<āUSD 15 | 20 (29.4) | 31 (53.5) | 1.0 | Ā |
ā>/=USD 15 | 48 (70.6) | 27 (46.6) | 0.36 (0.2ā0.8) | 0.01* |
Formal Education | ||||
āNone | 9 (13. 2) | 18 (31.0) | 1.0 | Ā |
āPrimary | 23 (33.8) | 16 (27.6) | 0.35 (0.1ā1.0) | 0.04* |
āSecondary | 17 (25.0) | 10 (17.2) | 0.29 (0.1ā1.0) | 0.03* |
āTertiary | 19 (27.9) | 14 (24.1) | 0.37 (0.2ā0.8) | 0.06 |
History of ever smoking: | ||||
āNo | 59 (86.8) | 42 (72.4) | 1.0 | Ā |
āYes | 9 (13.2) | 16 (27.6) | 2.50 (1.0ā6.2) | 0.05 |
CRS | ||||
āNo | 62 (91.2) | 15 (25.9) | 1.0 | Ā |
āYes | 6 (8.8) | 43 (74.1) | 29.62(10.6ā82.4) | 0.01* |
Allergy symptoms | ||||
āNo | 57 (83.3) | 37 (63.8) | 1.0 | Ā |
āYes | 11 (16.2) | 21 (36.2) | 2.94 (1.3ā6.8) | 0.01* |
GERD | ||||
āNo | 64 (94.1) | 54 (93.1) | 1.0 | Ā |
āYes | 4 (5.9) | 4 (6.9) | 1.1 (0.3ā5.0) | 0.82 |
Nasal polyps: | ||||
āNo | 67 (98.5) | 46 (79.3) | 1.0 | Ā |
āYes | 1 9 1.5) | 12 (20.7) | 17.5(2.2ā139.0) | 0.01* |
Nasal discharge: | ||||
āNo | 64 (94.1) | 23 (37. 9) | 1.0 | Ā |
āYes | 4 (5.9) | 35 (60.3) | 24.40 (7.8ā76.1) | 0.01* |
Nasal mucosal edema | ||||
āNo | 63 (92.7) | 26 (44.8) | 1.0 | Ā |
āYes | 5 (7.4) | 32 (55.2) | 15.51 (5.5ā44.2) | 0.01* |
Number of CRS symptoms: | ||||
ā0 | 46 (67.7) | 6 (10.3) | 1.0 | Ā |
ā1 | 12 (17.7) | 7 (12.1) | 4.47 (1.3ā15.8) | 0.02* |
āā>ā1 | 10 (14.7) | 45 (77.6) | 34.5(11.6ā102.9) | 0.01* |